2026 Media Partners

Take a look at the media partners who decided to support the 9th RNA-Targeted Drug Discovery & Development Summit. If you are interested in a media partnership, please contact info@hansonwade.com.

BioPharmaTrend

Learn more:

BioPharma Asia

Learn more:

BioPharma Asia aims to keep its readers abreast of all developments in Manufacturing, Development, Quality Assurance, Outsourcing and Regulatory Affairs, with only the highest quality articles and webinars written and presented by the most respected authors/presenters associated with only end-user companies. So, ensuring the information will always be guaranteed to remain timely, informative, and unbiased.

www.biopharma-asia.com

Drug Discovery Online

Learn more:

Drug Discovery Online is a Life Science Connect community for scientists, executives, and innovators working at the front end of therapeutic development. It covers early-stage discovery, target validation, preclinical development, platform technology, and translational science. As part of the Life Science Connect network, Drug Discovery Online empowers discovery teams to advance promising therapies toward clinical readiness with confidence and strategic insight.

www.drugdiscoveryonline.com

Pharma Journalist

Learn more:

Pharma Journalist is one of the leading websites covering the needs of the global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims to provide fast and informative articles to its readers and subscribers.

www.pharmajournalist.com

RNA Society

Learn more:

The RNA Society was formed in 1993 to facilitate sharing and dissemination of experimental results and emerging concepts in ribonucleic acid research. The Society encompasses RNA research in the broadest sense: from the ribosome to the spliceosome, from RNA viruses to catalytic RNAs, and from long noncoding RNAs to microRNAs. We are a multidisciplinary society, representing molecular, evolutionary and structural biology, biochemistry, biomedical sciences, chemistry, genetics, and virology as they relate to questions of the structure and function of RNA and of ribonucleoprotein assemblies.

www.rnasociety.org

Explore the Agenda

Hear the latest industry advances in RNA target selection, structure-guided design, selective modulation and translational strategies across the full RNA-targeted small molecule pipeline and during our packed agenda, interactive roundtables, and panel discussions.

View the Full Event Guide

Partner With Us

Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.

Explore Sponsorship Options

Join Biopharma Experts

Connect with RNA-targeted small molecule leaders across discovery, preclinical and clinical development during our dedicated networking sessions to exchange insights, build collaborations and strengthen decisions from target selection to therapeutic impact.

2026 Media Partners